Dual-targeting inhibition of TNFR1 for alleviating rheumatoid arthritis by a novel composite nucleic acid nanodrug

Selective suppression of tumor necrosis factor (TNF) α-TNF receptor 1 (TNFR1) signaling is a potent solution for rheumatoid arthritis (RA). Herein, novel composite nucleic acid nanodrugs that simultaneously restrain TNF α binding and TNFR1 multimerization were designed to reinforce inhibition of TNF...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Xiaonan Wang, Fanfan Guo, Yi Zhang, Ziyi Wang, Jiaqi Wang, Rongrong Luo, Xiao Chu, Yongxing Zhao, Pengchao Sun
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2023-12-01
Schriftenreihe:	International Journal of Pharmaceutics: X
Schlagworte:	Aptamer Anti-inflammatory peptide Tumor necrosis factor receptor 1 Nanodrug Rheumatoid arthritis
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S2590156723000063
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!